Laboratorios Farmaceuticos Rovi SA (XMAD:ROVI)
€ 88.2 0.4 (0.46%) Market Cap: 4.51 Bil Enterprise Value: 4.55 Bil PE Ratio: 33.53 PB Ratio: 8.48 GF Score: 88/100

Laboratorios Farmaceuticos Rovi, S.A. - Special Call Transcript

Mar 19, 2019 / 09:00AM GMT
Release Date Price: €18.05 (+4.34%)
Operator

Good morning, ladies and gentlemen. Thank you for standing by. Welcome to today's positive top line results from Phase III Study of Doria Conference Call. (Operator Instructions)

I must advise you that this conference is being recorded today, the 19th March, 2019.

I would like to hand the conference over to your speaker today, Juan López-Belmonte. Please go ahead.

Javier López;Belmonte Encina
Laboratorios Farmaceuticos Rovi, S.A. - Second Deputy Chairman & CFO

Thank you, very much, and good morning to everyone. This is Javier López-Belmonte, CFO of ROVI. At this time, I would like to welcome everybody to this conference call to discuss Doria positive topline results, which will start in a moment. Let me please first introduce ROVI's attendees today. Juan López-Belmonte, CEO; Ibón Gutierro, Corporate R&D Director; Marta Campos, Investor Relations, and myself.

All lines are now mute to prevent any background noise. After the presentation, as the operator said, there will be a question-and-answer session.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot